None listed
Conditions
Interventions
Intervention1: Prof. (Dr.) Subheet Kumar Jain: Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar-143005
Intervention2: DHA: Commercial available DHA supplements already receiv
Sponsors
Department of Pharmaceutical Sciences Guru Nanak Dev University Amritsar
ICMRSRF to Shubham Thakur Under Supervision of Prof Dr Subheet Kumar Jain
Eligibility
Inclusion criteria
Inclusion criteria: Women were eligible for enrollment if they were between 12 and 24 week of gestation between 16 and 40 year of age and planning to deliver at a same hospital
Exclusion criteria
Exclusion criteria: • You have an active infection or other serious condition such as cardiac disease, cancer, lupus, hepatitis, HIV/AIDS, or a diagnosed alcohol or chemical dependency. • Subjects were excluded if they were carrying more than one fetus. • Had preexisting diabetes mellitus or systolic blood pressure 140 mm Hg at enrollment. • Had any serious health condition likely to affect the prenatal or postnatal growth and development of their offspring, • You are unable or unwilling to DHA supplement. • You have had a yellow fever vaccination within the last 30 days or plan to have it.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Therefore, the present study focusses on the documentation of reference range(s) in blood of pregnant women. The identification of reference range in blood might have diagnostic, prognostic and therapeutic significance in pregnant women. These results will appear to be the first detailed analyses framing the biochemical reference ranges from a pregnant woman in Indian population that so far not reported in the literature.Timepoint: For normal women- any time point and for pregnant (2-3 months gestation period). | — |
Secondary
| Measure | Time frame |
|---|---|
| Baseline references.Timepoint: 0 and 5 Months | — |
Countries
India
Contacts
Public ContactShubham Thakur
Guru Nanak Dev University, Amritsar
Outcome results
None listed